ARTICLE | Distillery Therapeutics
Cancer
December 11, 2018 2:43 PM UTC
Cell culture, patient sample and mouse studies suggest inhibiting SMARCA4 could help treat PTEN-deficient prostate cancer. Screening of a CRISPR single-guide RNA (sgRNA) library targeting 517 genes en...